𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Seroprevalence atlas of infections with oncogenic and non-oncogenic human papillomaviruses in Finland in the 1980s and 1990s

✍ Scribed by Matti Lehtinen; Marjo Kaasila; Kari Pasanen; Toni Patama; Johanna Palmroth; Päivi Laukkanen; Eero Pukkala; Pentti Koskela


Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
731 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Vaccines against high‐risk (hr) human papillomaviruses (HPVs) causing cervical cancer may soon be licensed. Thus, nature of HPV epidemics needs to be studied now. Random sampling for studies on HPV epidemiology was done from all 230,998 women belonging to the population‐based Finnish Maternity Cohort and having a minimum of 2 pregnancies between 1983 and 1994. First pregnancy serum specimens were retrieved for 7,805 subjects, and were analyzed for antibodies to HPV6/11, 16 and 18 with standard ELISAs. HPV16 seroprevalence almost doubled from the 1980s to the 1990s, and the epidemic spread to new areas in 23–31 year olds, i.e. the bulk of pregnant female population in the southwest part of the country. The HPV16 epidemic in the 14–22 year olds in 1983–1988 (1961–1974 birth cohorts) and in the 23–31 year olds in 1989–1994 (1958–1971 birth cohorts) overlapped with strong clustering of HPV16 and HPV18 infections in the latter (odds ratio 8.0, 95% confidence interval 6.6–9.7). Similar clustering of HPV16 and HPV6/11 infections was not found. The epidemic and the clustering may be due to high transmission probability of the hrHPV types and increase in sexual activity of the index birth cohorts. © 2006 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Moderate variation of the oncogenic pote
✍ Krisztina Szőke; Tamás Sápy; Zoárd Krasznai; Zoltán Hernádi; Györgyi Szládek; Gy 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

The oncogenic potential of human papillomavirus (HPV) infection was assessed by following the disease course in 455 patients who had had a routine diagnostic Hybrid Capture HPV test due to squamous cell abnormalities of the uterine cervix as detected by cytology and/or colposcopy. At entry, 308 pati

Evaluation of oncogenic human papillomav
✍ Joseph Monsonego; Michael G. Hudgens; Laurent Zerat; Jean-Claude Zerat; Kari Syr 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 335 KB 👁 2 views

The APTIMA V R HPV Assay (AHPV) allows detection of 14 high-risk human papillomavirus (HPV) RNA types in cervical specimens. Until present, the assay has been compared to HPV DNA tests only in triage settings. Herein, we compare AHPV with a DNA assay (Hybrid Capture V R 2; HC2) and liquid-based cyto

Genetic characterization of the human pa
✍ Julia L. Hecht; Anna S. Kadish; Gang Jiang; Robert D. Burk 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 991 KB

HPV 18 is associated with 2 divergent phenotypes: (i) aggressive cervical cancer and a preponderance of cancer relative to cervical intra-epithelial neoplasia (CIN) and (ii) benign warty lesions of the cervix. The €2 gene of HPV 18 encodes a regulatory protein that represses viral oncogene transcrip